Clinical Trial Update: Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease. [Phase 2]

View source ↗

Summary

Phase 2 multicenter double-blind randomized trial evaluating the safety and efficacy of transplanted fetal porcine cells in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Transplanted fetal porcine cells

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED